News
November 10, 2021
Approval from the Dutch Health Authorities to initiate a Phase I study with Matisse Pharmaceuticals' lead compound M6229 in sepsis.
Read more
March 1, 2020
Matisse Pharmaceuticals raises financing for its phase I/IIa clinical trial treating patients suffering from sepsis.
Read more